Amgen (AMGN) closed at $328.35 on Friday, 2.29% higher on the day.
Amgen’s stock price has increased 14.00% so far this year, more than the 12.69% advance registered by the overall Dow Jones Industrial Average (DJIA) index.
On Friday, the DJIA was broadly unchanged to close at 42,863.86 points. The three leaders were JPMorgan Chase (JPM), Boeing (BA) and Goldman Sachs (GS), while the three laggards were Salesforce (CRM), Apple (AAPL) and Nike (NKE).
Back to Amgen, its latest earnings report from fiscal Q2 showed that earnings per share (EPS) were at $4.97. Revenue, meanwhile, stood at $8.39 billion.
The next earnings report for Amgen will be published on October 30.
Analysts expect Amgen’s earnings per share to come in at $5.13 for Q3, while revenue is seen at $8.51 billion.
(An automation tool was used in creating this post.)
Read the full article here
